SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-24-006959
Filing Date
2024-01-26
Accepted
2024-01-26 16:00:20
Documents
14
Period of Report
2024-01-24
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea192296-8k_optimizerx.htm   iXBRL 8-K 26633
2 PRESS RELEASE, DATED JANUARY 25, 2024 ea192296ex99-1_optimizerx.htm EX-99.1 16500
3 GRAPHIC ex99-1_001.jpg GRAPHIC 6689
  Complete submission text file 0001213900-24-006959.txt   232320

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE oprx-20240124.xsd EX-101.SCH 3021
5 XBRL LABEL FILE oprx-20240124_lab.xml EX-101.LAB 34240
6 XBRL PRESENTATION FILE oprx-20240124_pre.xml EX-101.PRE 22363
8 EXTRACTED XBRL INSTANCE DOCUMENT ea192296-8k_optimizerx_htm.xml XML 3303
Mailing Address 260 CHARLES STREET SUITE 302 WALTHAM MA 02453
Business Address 260 CHARLES STREET SUITE 302 WALTHAM MA 02453 248-651-6558
OptimizeRx Corp (Filer) CIK: 0001448431 (see all company filings)

IRS No.: 261265381 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38543 | Film No.: 24567667
SIC: 7389 Services-Business Services, NEC
(CF Office: 07 Trade & Services)